Literature DB >> 15621564

Innate and acquired immunity in the pathogenesis of Chagas disease.

Denise Golgher1, Ricardo T Gazzinelli.   

Abstract

The apparent discrepancy between the intensity of inflammatory reaction and scarce number of parasites in chronic chagasic myocarditis prompt several investigators to hypothesize that an autoimmune process was involved in the pathogenesis of Chagas disease. Here, we recapitulate diverse molecular and cellular mechanisms of innate and acquired immunity involved in the control of parasite replication and in the build up of myocarditis observed during infection with Trypanosoma cruzi. In addition, we review the immunoregulatory mechanisms responsible for preventing excessive immune response elicited by this protozoan parasite. Ongoing studies in this research area may provide novel therapeutic strategies that could enhance the immunoprotective response while preventing the deleterious parasite-elicited responses observed during Chagas disease.

Entities:  

Mesh:

Year:  2004        PMID: 15621564     DOI: 10.1080/08916930410001713115

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  24 in total

1.  Are increased frequency of macrophage-like and natural killer (NK) cells, together with high levels of NKT and CD4+CD25high T cells balancing activated CD8+ T cells, the key to control Chagas' disease morbidity?

Authors:  D M Vitelli-Avelar; R Sathler-Avelar; R L Massara; J D Borges; P S Lage; M Lana; A Teixeira-Carvalho; J C P Dias; S M Elói-Santos; O A Martins-Filho
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

2.  Requirement of UNC93B1 reveals a critical role for TLR7 in host resistance to primary infection with Trypanosoma cruzi.

Authors:  Braulia C Caetano; Bianca B Carmo; Mariane B Melo; Anna Cerny; Sara L dos Santos; Daniella C Bartholomeu; Douglas T Golenbock; Ricardo T Gazzinelli
Journal:  J Immunol       Date:  2011-07-13       Impact factor: 5.422

3.  Regulation of Trypanosoma cruzi-induced myocarditis by programmed death cell receptor 1.

Authors:  Fredy R S Gutierrez; Flávia S Mariano; Carlo J F Oliveira; Wander R Pavanelli; Paulo M M Guedes; Grace K Silva; Ana P Campanelli; Cristiane M Milanezi; Miyuki Azuma; Tasuku Honjo; Mauro M Teixeira; Julio C S Aliberti; João S Silva
Journal:  Infect Immun       Date:  2011-02-28       Impact factor: 3.441

4.  Identification of Anti-Trypanosoma cruzi Lead Compounds with Putative Immunomodulatory Activity.

Authors:  Dayane Andriotti Otta; Fernanda Fortes de Araújo; Vitor Bortolo de Rezende; Elaine Maria Souza-Fagundes; Silvana Maria Elói-Santos; Matheus Fernandes Costa-Silva; Raiany Araújo Santos; Heloísa Alves Costa; Jair Lage Siqueira-Neto; Olindo Assis Martins-Filho; Andréa Teixeira-Carvalho
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

5.  T-Cell Immunophenotyping and Cytokine Production Analysis in Patients with Chagas Disease 4 Years after Benznidazole Treatment.

Authors:  Mauricio Llaguno; Marcos Vinicius da Silva; Lara Rocha Batista; Djalma Alexandre Alves da Silva; Rodrigo Cunha de Sousa; Luiz Antonio Pertili Rodrigues de Resende; Valdo Jose Dias da Silva; Eliane Lages-Silva; Carlo José Freire Oliveira; Juliana Reis Machado; Denise Bertulucci Rocha Rodrigues; Dalmo Correia; Virmondes Rodrigues
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

6.  BAFF mediates splenic B cell response and antibody production in experimental Chagas disease.

Authors:  Daniela A Bermejo; María C Amezcua-Vesely; Carolina L Montes; María C Merino; Ricardo C Gehrau; Hugo Cejas; Eva V Acosta-Rodríguez; Adriana Gruppi
Journal:  PLoS Negl Trop Dis       Date:  2010-05-04

7.  Granulocyte colony-stimulating factor partially repairs the damage provoked by Trypanosoma cruzi in murine myocardium.

Authors:  Mariela Natacha González; Nilay Dey; Nisha Jain Garg; Miriam Postan
Journal:  Int J Cardiol       Date:  2013-04-15       Impact factor: 4.164

8.  Trypanosoma cruzi targets Akt in host cells as an intracellular antiapoptotic strategy.

Authors:  Marina V Chuenkova; Mercio PereiraPerrin
Journal:  Sci Signal       Date:  2009-11-17       Impact factor: 8.192

9.  Trans-sialidase from Trypanosoma brucei as a potential target for DNA vaccine development against African trypanosomiasis.

Authors:  Marcelo Sousa Silva; Duarte Miguel F Prazeres; Andreia Lança; Jorge Atouguia; Gabriel Amaro Monteiro
Journal:  Parasitol Res       Date:  2009-07-07       Impact factor: 2.289

10.  Different parasite inocula determine the modulation of the immune response and outcome of experimental Trypanosoma cruzi infection.

Authors:  Diego C Borges; Natalia M Araújo; Cristina R Cardoso; Javier E Lazo Chica
Journal:  Immunology       Date:  2013-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.